Building a Culture of Quality to Demonstrate Value and Improve Equity
With support from the Robert Wood Johnson Foundation, AMCHP developed the Birth Outcomes Collaborative that builds off the existing infrastructure of the CoIIN to reduce infant mortality across states in regions IV/VI, by facilitating the spread of evidence based practices/innovations to improve birth outcomes/reduce infant mortality; increase the use and application of QI methods to address birth outcomes, and demonstrate the value of multidisciplenary investments in MCH interventions to improve birth outcomes.
This workshop will highlight select states experiences in the Collaborative to improve public health/health care processes and precursors to birth outcomes, using collaborative learning and QI to leverage the work of CoIIN. Specifically, state MCH Directors will share progress and lessons learned to address their priority strategies through performing economic analyses for interventions and strategies identified through CoIIN.
Learning Areas:Biostatistics, economics
Implementation of health education strategies, interventions and programs
Other professions or practice related to public health
Planning of health education strategies, interventions, and programs
Public health administration or related administration
Discuss the spread of evidence based practices/innovations to improve birth outcomes/reduce infant mortality Describe the use and application of QI methods to address birth outcomes Demonstrate the value of investments in multi-stakeholder interventions to improve birth outcomes Discuss continued progress toward health equity in birth outcomes
Keyword(s): Maternal and Child Health, Health Disparities/Inequities
Qualified on the content I am responsible for because: I contribute to the advancement of MCH programs and lead technical assistance efforts for the organization related to womenâs health and improving birth outcomes.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.